Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to $1.2 million.

  • Evolus' Capital Expenditures rose 966.27% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 10348.97%. This contributed to the annual value of $3.4 million for FY2024, which is 19038.13% up from last year.
  • Per Evolus' latest filing, its Capital Expenditures stood at $1.2 million for Q3 2025, which was up 966.27% from $1.6 million recorded in Q2 2025.
  • Evolus' 5-year Capital Expenditures high stood at $1.6 million for Q2 2025, and its period low was -$21000.0 during Q3 2021.
  • Over the past 5 years, Evolus' median Capital Expenditures value was $390000.0 (recorded in 2022), while the average stood at $580210.5.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 10363.32% in 2021, then skyrocketed by 2750000.0% in 2022.
  • Evolus' Capital Expenditures (Quarter) stood at -$3000.0 in 2021, then skyrocketed by 27500.0% to $822000.0 in 2022, then tumbled by 81.51% to $152000.0 in 2023, then skyrocketed by 507.89% to $924000.0 in 2024, then surged by 30.19% to $1.2 million in 2025.
  • Its Capital Expenditures was $1.2 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.5 million in Q1 2025.